Metagenomi Therapeutics (MGX) Q2 2026 Earnings

19MayConfirmed
Q3 2025
Q4 2025
Q1 2026
Next
-0.62
-0.59
-0.57
-0.54

Details

Expected EPS
-0.553408
Actual EPS
N/A
Surprise EPS
0.55
Surprise Percent
+100%

Description

Metagenomi Therapeutics (MGX) will report earnings of for Q2 2026 on May 19, 2026.

0 Comments

Share your thoughts